331 related articles for article (PubMed ID: 23726000)
1. Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: a phase 2 trial of 3-dimensional conformal radiation therapy-accelerated partial breast irradiation following lumpectomy for stages I and II breast cancer.
Chafe S; Moughan J; McCormick B; Wong J; Pass H; Rabinovitch R; Arthur DW; Petersen I; White J; Vicini FA
Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):854-9. PubMed ID: 23726000
[TBL] [Abstract][Full Text] [Related]
2. Four-year efficacy, cosmesis, and toxicity using three-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
Chen PY; Wallace M; Mitchell C; Grills I; Kestin L; Fowler A; Martinez A; Vicini F
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):991-7. PubMed ID: 19515514
[TBL] [Abstract][Full Text] [Related]
3. Interim cosmetic results and toxicity using 3D conformal external beam radiotherapy to deliver accelerated partial breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy.
Vicini FA; Chen P; Wallace M; Mitchell C; Hasan Y; Grills I; Kestin L; Schell S; Goldstein NS; Kunzman J; Gilbert S; Martinez A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1124-30. PubMed ID: 17967306
[TBL] [Abstract][Full Text] [Related]
4. Accelerated partial breast irradiation using 3D conformal radiotherapy: toxicity and cosmetic outcome.
Gatti M; Ponzone R; Bresciani S; Panaia R; Kubatzki F; Maggiorotto F; Di Virgilio MR; Salatino A; Baiotto B; Montemurro F; Stasi M; Gabriele P
Breast; 2013 Dec; 22(6):1136-41. PubMed ID: 23958374
[TBL] [Abstract][Full Text] [Related]
5. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
6. Identifying patients who are unsuitable for accelerated partial breast irradiation using three-dimensional external beam conformal techniques.
Shikama N; Nakamura N; Kunishima N; Hatanaka S; Sekiguchi K
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e313-8. PubMed ID: 22417799
[TBL] [Abstract][Full Text] [Related]
7. Three-year outcomes of a Canadian multicenter study of accelerated partial breast irradiation using conformal radiation therapy.
Berrang TS; Olivotto I; Kim DH; Nichol A; Cho BC; Mohamed IG; Parhar T; Wright JR; Truong P; Tyldesley S; Sussman J; Wai E; Whelan T
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1220-7. PubMed ID: 20971571
[TBL] [Abstract][Full Text] [Related]
8. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
[TBL] [Abstract][Full Text] [Related]
9. Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using three-dimensional conformal external beam radiation therapy.
Olivotto IA; Whelan TJ; Parpia S; Kim DH; Berrang T; Truong PT; Kong I; Cochrane B; Nichol A; Roy I; Germain I; Akra M; Reed M; Fyles A; Trotter T; Perera F; Beckham W; Levine MN; Julian JA
J Clin Oncol; 2013 Nov; 31(32):4038-45. PubMed ID: 23835717
[TBL] [Abstract][Full Text] [Related]
10. Five-year outcomes and toxicities using 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
Shah C; Wilkinson JB; Lanni T; Jawad M; Wobb J; Fowler A; Wallace M; Chen P; Grills IS; Vicini F
Clin Breast Cancer; 2013 Jun; 13(3):206-11. PubMed ID: 23103365
[TBL] [Abstract][Full Text] [Related]
11. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation.
Rodríguez N; Sanz X; Dengra J; Foro P; Membrive I; Reig A; Quera J; Fernández-Velilla E; Pera Ó; Lio J; Lozano J; Algara M
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1051-7. PubMed ID: 24161420
[TBL] [Abstract][Full Text] [Related]
12. Partial breast radiation therapy with proton beam: 5-year results with cosmetic outcomes.
Bush DA; Do S; Lum S; Garberoglio C; Mirshahidi H; Patyal B; Grove R; Slater JD
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):501-5. PubMed ID: 25084608
[TBL] [Abstract][Full Text] [Related]
13. Preoperative radiation therapy significantly increases patient eligibility for accelerated partial breast irradiation using 3D-conformal radiotherapy.
Nichols EM; Feigenberg SJ; Marter K; Cheston SB; Lasio G; Tkaczuk K; Kesmodel S; Buras R; Regine WF
Am J Clin Oncol; 2013 Jun; 36(3):232-8. PubMed ID: 22549267
[TBL] [Abstract][Full Text] [Related]
14. The effect of dose-volume parameters and interfraction interval on cosmetic outcome and toxicity after 3-dimensional conformal accelerated partial breast irradiation.
Leonard KL; Hepel JT; Hiatt JR; Dipetrillo TA; Price LL; Wazer DE
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):623-9. PubMed ID: 22867895
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.
Kuske RR; Winter K; Arthur DW; Bolton J; Rabinovitch R; White J; Hanson W; Wilenzick RM
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):45-51. PubMed ID: 16503383
[TBL] [Abstract][Full Text] [Related]
16. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
[TBL] [Abstract][Full Text] [Related]
17. Partial breast irradiation delivered with proton beam: results of a phase II trial.
Bush DA; Slater JD; Garberoglio C; Do S; Lum S; Slater JM
Clin Breast Cancer; 2011 Aug; 11(4):241-5. PubMed ID: 21729673
[TBL] [Abstract][Full Text] [Related]
18. Predictors of adverse cosmetic outcome in the RAPID trial: an exploratory analysis.
Peterson D; Truong PT; Parpia S; Olivotto IA; Berrang T; Kim DH; Kong I; Germain I; Nichol A; Akra M; Roy I; Reed M; Fyles A; Trotter T; Perera F; Balkwill S; Lavertu S; Elliott E; Julian JA; Levine MN; Whelan TJ;
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):968-76. PubMed ID: 25832689
[TBL] [Abstract][Full Text] [Related]
19. Early side effects of three-dimensional conformal external beam accelerated partial breast irradiation to a total dose of 40 Gy in one week (a phase II trial).
Bourgier C; Pichenot C; Verstraet R; El Nemr M; Heymann S; Biron B; Delaloge S; Mathieu MC; Garbay JR; Bourhis J; Taghian AG; Marsiglia H
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1228-35. PubMed ID: 20932662
[TBL] [Abstract][Full Text] [Related]
20. Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/ II breast carcinoma.
Vicini F; Winter K; Wong J; Pass H; Rabinovitch R; Chafe S; Arthur D; Petersen I; White J; McCormick B
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):1120-7. PubMed ID: 19910132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
